Lack of a role for MRP1 in platinum drug resistance in human ovarian cancer cell lines

British Journal of Cancer

Volumn 78, Issue 2, 1998, Pages 175-180

  Sharp, S Y ^a   Smith, V ^a   Hobbs, S ^a   Kelland, L R ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Human ovarian carcinoma cell line; MRP1; Platinum resistance

Indexed keywords

CISPLATIN; DOXORUBICIN; ETOPOSIDE; MULTIDRUG RESISTANCE PROTEIN; PACLITAXEL; PLATINUM DERIVATIVE; VINBLASTINE; VINCRISTINE;

ARTICLE; CONTROLLED STUDY; CROSS RESISTANCE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; OVARY CARCINOMA; PRIORITY JOURNAL; VECTOR CONTROL;

EID: 0031841273     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.461     Document Type: Article

References (32)

1. Andrews PA and Howell SB (1990) Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance. Cancer Cells 2: 93-100
2. Barrand MA, Rhodes T, Center MS and Twentyman PR (1993) Chemosensitisation and drug accumulation effects of cyclosporin A, PSC833 and verapamil in human MDR large cell lung cancer cells expressing a 190 K membrane protein distinct from P-glycoprotein. Eur J Cancer 29A: 408-415
3. Behrens BC, Hamilton TC, Masuda H, Grotzinger KR, Whang-Peng J, Louie KG, Knutsen T, McKoy WM, Young R and Ozols RF (1987) Characterization of a cis-diamminedichloroplatinum (II)-resistant human ovarian carcinoma cell line and its use in evaluation of platinum analogs. Cancer Res 47: 414-418
4. Cole SPC, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AMV and Deeley RG (1992) Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258: 1650-1654
5. Cole SPC, Sparks KE, Fraser K, Loe DW, Grant CE, Wilson GM and Deeley RG (1994) Pharmacological characterization of multidrug resistant MRP1-transfected human tumor cells. Cancer Res 54: 5902-5910
6. De Vries EGE, Muller M, Meijer C, Jansen PLM and Mulder NH (1995) Role of glutathione S-conjugate pump in cisplatin resistance. J Natl Cancer Inst 87: 537-538
7. Fujii R, Mutoh M, Sumizawa T, Chen ZS, Yoshimura A and Akiyama S(1994) Adenosine triphosphate-dependent transport of leukotriene C4 by membrane vesicles prepared from cisplatin-resistant human epidermoid carcinoma tumor cells. J Natl Cancer Inst 86: 1781-1784
8. Hills CA, Kelland HK. Abel G, Siracky J. Wilson AP and Harrap KR (1989) Biological properties of ten human ovarian careinoma cell lines: calibration in vitro against four platinum complexes. Br J Cancer 59: 527-534
9. Holford J. Sharp SY, Murrer BA, Abrams M and Kelland LR (1998) In vitro circumvention of cisplatin resistance by the novel sterically hindered platinum complex AMD473 Br J Cancer 77: 366-373
10. Ishikawa T, Wright C and Ishizuka H (1994) GS-X pump is functionally overexpressed in cis-diamininedichloroplatinum (II)-resistant human leukemia HL-60 cells and down regulated by cell differentiation. J Biol Chem 269: 29085-29093
11. Ishikawa T, Bao JJ, Yamane Y, Akimuru K, Frindrich K, Wright CD and Kuo MT (1996) Coordinated induction of MRP1/GS-X pump and gamma glutamylcysteine synthetase by heavy metals in human leukemia cells. J Biol Chem 271: 14981-14988
12. Izquierdo MA, Shoemaker RH, Flens MC, Scheffer GL, Wu L, Prather TR and Scheper RJ (1996) Overlapping phenotypes of multidrug resistance among panels of human cancer cell lines. Int J Cancer 65: 230-237
13. Jedlitschky G, Leier I, Buchholz U, Barnouin K, Kurz G and Keppler D (1996) Transport of glutathione, glucuronate, and sulfate conjugates by the MRP1 gene-encoded conjugate export pump. Cancer Res 56: 988-994
14. Juliano RL and Ling VA (1976) A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 455: 152-162
15. Kavallaris M (1997) The role of multidrug resistance-associated protein (MRP1) expression in multidrug resistance. Anti-Cancer Drugs 8: 17-25
16. Kelland LR, Mistry P. Loh SY, O'Neill CF, Murrer BA and Harrap KR (1992) Mechanism-related circumvention of acquired cis-diamminedichloroplatinum (II) resistance using two pairs of human ovarian carcinoma cell lines by ammine/amine platinum (IV) dicarboxlyates cancer Res 52: 3857-3864
17. Kelland LR, Abel G, McKeage MJ, Jones M, Goddard PM, Valenti M, Murrer BA and Harrap KR (1993) Preclinical antitumor evaluation of bis-acctato-ammine-dichloro-cyclohexylamine platinum (IV): an orally active platinum drug. Cancer Res 53: 2581-2586
18. Kelland LR, Barnard CFJ, Mellish KJ, Jones M, Goddard PM, Valenti M, Bryant A, Murrer BA and Harrap KR (1994) A novel trans-platinum coordination complex possessing in vitro and in vivo antitumor activity. Cancer Res 54: 5618-5622
19. Loehrer PJ and Einhorn LH (1984) Cisplatin. Ann Int Med 100: 704-713
20. Loh SY, Mistry P, Kelland LR, Abel G and Harrap KR (1992) Reduced drug accumulation as a major mechanism of acquired resistance to cisplatin in a human ovarian carcinoma cell line: circumention studies using novel platinum (II) and (IV) ammine/amine complexes. Br J Cancer 66: 1109-1115
21. de la Luna S, Soria I, Pulido D, Ortin J and Jimenez A (1988) Efficient transformation of mammalian cells with constructs containing a puromycin-resistance marker. Gene 62: 121-126
22. McKeage MJ, Abel G, Kelland LR and Harrap KR (1994) Mechanism of action of an orally administered platinum complex [ammine bis butyrato cyclohexylamine dichloroplatinum (IV) (JM221)] in intrinsically cisplatin-resistant human ovarian carcinoma in vitro. Br J Cancer 69: 1-7
23. Mistry P, Kelland LR, Abel G, Sidhar S and Harrap KR (1991) The relationships between glutathione. glutathione-S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell lines. Br J Cancer 64: 215-220
24. Muller M, Meijer C, Zaman GJR, Borst P, Scheper RJ, Mulder NH, de Vries EGE and Jansen PLM (1994) Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. Proc Natl Acad Sci USA 91: 13033-13037
25. Rees S, Coole J, Stables J, Goodson S, Harris S and Lee MG (1996) Bicistronic vector for the creation of stable mammalian cell lines that predisposes all antibiotic-resistant cells to express recombinant protein. Bio Techniques 20: 102-110
26. Scheffer GL, Wijngaard PLJ, Flens MJ, Izquierdo MA, Slovak ML, Pinedo HM, Meijer CJLM, Clevers HC and Scheper RJ (1995) The drug resistance-related protein LRP is the human major vault protein. Nature Med 1: 578-582
27. Schneider E, Yamazaki H, Sinha BK and Cowan KH (1995) Buthionine sulphoximine-mediated sensitisation of etoposide-resistant human breast cancer MCF7 cells overexpressing the multidrug resistance-associated protein involves increased drug accumulation. Br J Cancer 71: 738-743
28. Sharp SY, Rowlands MG, Jarman M and Kelland LR (1994) Effects of a new antioestrogen, idoxifene, on cisplatin- and doxorubicin-sensitive and -resistant human ovarian carcinoma cell lines Br J Cancer 70: 409-414
29. Taniguchi K, Wada M, Kohno K, Nakamura T, Kawabe T, Kawakami M, Kagotani K, Okumura K, Akiyama SI and Kuwano M (1996) A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation. Cancer Res 56: 4124-4129
30. Versantvoort CHM, Broxierman HJ, Bagrij, Scheper RJ and Twentyman PR (1995) Regulation by glutathione of drug transport in multidrug-resistant human lung tumour cell lines overexpressing multidrug resistance-associated protein. Br J Cancer 72: 82-89
31. Zaman GJR, Flens MJ, van Leusden MR, de Haas M, Mulder HS, Lankelma J, Pinedo HM, Scheper RJ, Baas F, Broxterman HJ and Borst P (1994) The human multidrug resistance-associated protein MRP1 is a plasma membrane drug-efflux pump. Proc Natl Acad Sci USA 91: 8822-8826
32. Zaman GJR, Lankelma J, van Tellingen O, Beijnen J, Dekker H, Paulusma CC, Oude Elferink RP, Baas F and Borst P (1995) Role of glutathione in the export of compounds from cells by the multidrug resistance-associated protein. Proc Natl Acad Sci USA 92: 7690-7694